www.finanznachrichten.de ·
68533464 sino biological inc sino biological launches xpressmax cell free protein synthesis kit accelerating ai powered high throughput antibody drug disco 008
Topic context
This topic has been covered 382120 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedSino Biological's new kit accelerates AI-driven antibody drug discovery by reducing protein synthesis time and cost. The product targets biotech and pharma R&D labs, potentially increasing throughput for early-stage drug development. Impact is product-specific and limited to the protein synthesis tools market; no broad sector disruption expected.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Sino Biological launched XPressMAX Cell-Free Protein Synthesis Kit.
- Kit enables protein synthesis in 3 hours with >99% success rate.
- Allows validation of over 2,000 scFv/VHH molecules in 3-4 weeks.
- Uses E. coli lysate for direct protein production from plasmid or PCR templates.
- Sino Biological serves researchers in over 90 countries.
Related stories
fool.com
Keysight Keys Q2 2026 Earnings Transcript
fool.com
Canaan Can Q1 2026 Earnings Transcript
livemint.com
Haryana Bars Petrol Diesel Cabs for Aggregators What Means Pm Modis Austerity Push Ncrs Aqi Fuel News
zerohedge.com
New Fed Chair Pledges Regime Change Fight Inflation Heres What Could Mean Practice
fool.com